Copyright
©2011 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Apr 14, 2011; 17(14): 1879-1888
Published online Apr 14, 2011. doi: 10.3748/wjg.v17.i14.1879
Published online Apr 14, 2011. doi: 10.3748/wjg.v17.i14.1879
Cetuximab plus irinotecan in pretreated metastatic colorectal cancer patients: The ELSIE study
Robert Lim, Department of Hematology-Oncology, National University Hospital, 119074 Singapore, Singapore
Yan Sun, Department of Medical Oncology, Cancer Hospital and Institute, Chinese Academy of Medical Science, Beijing 100021, China
Seock-Ah Im, Division of Hematology-Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul 110-744, South Korea
Ruey-Kuen Hsieh, Department of Oncology-Hematology, Mackay Memorial Hospital, Taipei 104, Taiwan, China
Tsz Kok Yau, Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong, China
Anthony Bonaventura, Department of Medical Oncology, Calvary Mater Newcastle Hospital, Waratah, New South Wales, 2298, Australia
Arkom Cheirsilpa, National Cancer Institute, Bangkok, 10400, Thailand
Regina Esser, Global Clinical Development Unit Oncology, Merck KGaA, Darmstadt, 64293, Germany
Matthias Mueser, Medical Affairs Oncology Asia Pacific, Merck Serono, 609927 Singapore, Singapore
Suresh Advani, Jaslok Hospital and Research Centre, Mumbai 400026, India
Author contributions: Lim R, Sun Y, Hsieh RK, Mueser M and Esser R designed the study; Lim R, Sun Y, Im SA, Hsieh RK, Yau TK, Bonaventura A, Cheirsilpa A and Advani S recruited patients to the study; Sun Y, Im SA, Hsieh RK, Yau TK, Bonaventura A, Cheirsilpa A, Esser R and Advani S performed the research; Sun Y, Im SA, Hsieh RK, Yau TK, Bonaventura A, Cheirsilpa A and Advani S collected data; Lim R, Hsieh RK, Mueser M and Esser R analyzed the data; Lim R, Bonaventura A, Mueser M and Esser R wrote and edited the manuscript; all authors gave final approval to manuscript submission.
Supported by Merck KGaA, Darmstadt, Germany
Correspondence to: Dr. Robert Lim, Department of Hematology-Oncology, National University Hospital, 5 Lower Kent Ridge Road, 119074 Singapore, Singapore. robert_lim@nuhs.edu.sg
Telephone: +65-67724616 Fax: +65-67775545
Received: November 15, 2010
Revised: November 22, 2010
Accepted: November 29, 2010
Published online: April 14, 2011
Revised: November 22, 2010
Accepted: November 29, 2010
Published online: April 14, 2011
Core Tip